These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2915241)

  • 1. Selective intraperitoneal biochemical modulation of methotrexate by dipyridamole.
    Goel R; Cleary SM; Horton C; Balis FM; Zimm S; Kirmani S; Howell SB
    J Clin Oncol; 1989 Feb; 7(2):262-9. PubMed ID: 2915241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamole.
    Isonishi S; Kirmani S; Kim S; Plaxe SC; Braly PS; McClay EF; Howell SB
    J Natl Cancer Inst; 1991 May; 83(9):621-6. PubMed ID: 2023280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of 5-fluorouracil and dipyridamole administered by seventy-two-hour concurrent continuous infusion.
    Remick SC; Grem JL; Fischer PH; Tutsch KD; Alberti DB; Nieting LM; Tombes MB; Bruggink J; Willson JK; Trump DL
    Cancer Res; 1990 May; 50(9):2667-72. PubMed ID: 2328492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches to intraperitoneal drug delivery.
    Howell SB; Kirmani S; Goel R
    Acta Med Austriaca; 1989; 16(3-4):61-4. PubMed ID: 2514552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate and dipyridamole combination chemotherapy based upon inhibition of nucleoside salvage in humans.
    Willson JK; Fischer PH; Remick SC; Tutsch KD; Grem JL; Nieting L; Alberti D; Bruggink J; Trump DL
    Cancer Res; 1989 Apr; 49(7):1866-70. PubMed ID: 2924325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of intraperitoneally administered dipyridamole in cancer patients.
    Chan TC; Coppoc GL; Zimm S; Cleary S; Howell SB
    Cancer Res; 1988 Jan; 48(1):215-8. PubMed ID: 3334996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraperitoneal infusion therapy of MTX and 5-FU for advanced gastric cancer and its peritoneal metastasis].
    Takamatsu S; Maruyama M; Sugano N; Katada M; Ebuchi M
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1619-21. PubMed ID: 7574775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics.
    Morgan RJ; Doroshow JH; Synold T; Lim D; Shibata S; Margolin K; Schwarz R; Leong L; Somlo G; Twardowski P; Yen Y; Chow W; Lin P; Paz B; Chu D; Frankel P; Stalter S
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5896-901. PubMed ID: 14676112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic basis for the use of dipyridamole to increase the selectivity of intraperitoneally delivered methotrexate.
    Goel R; Sanga R; Howell SB
    Cancer Chemother Pharmacol; 1989; 25(3):167-72. PubMed ID: 2598406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized comparison of high-dose infusion methotrexate versus standard-dose weekly therapy in head and neck squamous cancer.
    Taylor SG; McGuire WP; Hauck WW; Showel JL; Lad TE
    J Clin Oncol; 1984 Sep; 2(9):1006-11. PubMed ID: 6332178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial.
    Yamao T; Shimada Y; Shirao K; Ohtsu A; Ikeda N; Hyodo I; Saito H; Iwase H; Tsuji Y; Tamura T; Yamamoto S; Yoshida S
    Jpn J Clin Oncol; 2004 Jun; 34(6):316-22. PubMed ID: 15333683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraperitoneal repeated chemotherapy using CDDP combined with MMC for carcinomatous peritonitis].
    Arai K; Kitamura M; Miyashita K
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1642-4. PubMed ID: 8373237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant treatment of gastric cancer with peritoneal dissemination.
    Yonemura Y; Bandou E; Sawa T; Yoshimitsu Y; Endou Y; Sasaki T; Sugarbaker PH
    Eur J Surg Oncol; 2006 Aug; 32(6):661-5. PubMed ID: 16621433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ; Meyers FJ; Houston J; Lauder I
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavity.
    Markman M; Cleary S; Lucas WE; Howell SB
    J Clin Oncol; 1985 Jul; 3(7):925-31. PubMed ID: 3894586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Report of case who survived more than five years after repeated intraperitoneal chemotherapy with cisplatin and 5-fluorouracil for treatment of macroscopically negative but microscopically positive peritoneal dissemination of gastric cancer].
    Hiratsuka M; Furukawa H; Yasuda T; Murata K; Nakano H; Ohigashi H; Kameyama M; Sasaki Y; Kabuto T; Ishikawa O; Imaoka S
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1445-8. PubMed ID: 9703850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis.
    Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Yamashita H; Watanabe T
    Cancer; 2013 Sep; 119(18):3354-8. PubMed ID: 23798046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of dipyridamole with 5-fluorouracil and folinic acid.
    Budd GT; Jayaraj A; Grabowski D; Adelstein D; Bauer L; Boyett J; Bukowski R; Murthy S; Weick J
    Cancer Res; 1990 Nov; 50(22):7206-11. PubMed ID: 2224854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of peritoneal dialysis for delivery of chemotherapy to intraperitoneal malignancies.
    Speyer JL; Myers CE
    Recent Results Cancer Res; 1980; 74():264-9. PubMed ID: 7444143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.